Nanoparticles loaded in consumable polymeric oral films: A smart dosage form design for oral administration

Sinha Suhani

doi:10.30574/gscbps.2020.12.1.0153

Authors

Sinha Suhani Department of Pharmacy, School of Medical and Allied Sciences, G D Goenka University, Gurugram-122103, India.

DOI:

https://doi.org/10.30574/gscbps.2020.12.1.0153

Keywords:

Oral film, Nanoparticles, Nanopharmaceutical, Nanodrugs, Chitosan, FDA approved, Bioavailability, Permeability, Dissolution

Abstract

This review article provides an overview of nanoparticles in polymeric oral thin films as smart, non-parenteral and non-invasive route of drug administration to achieve patient compliance for varied therapeutic applications. The increasing research trend towards developing biocompatible and biodegradable nanoparticles as sustained release mucoadhesive patches with potential to improve pharmacokinetics and bioavailability significantly has given impetus to drug repurposing of existing molecules to new boundaries. Most widely used polymers to prepare nanoparticles include alginate and chitosan as they are biodegradable, biocompatible, demonstrated low toxicity in in vitro and in vivo models and has already been approved for dietary use and wound dressing applications. Chitosan particularly has been used as a carrier for polymeric nanoparticles for drug delivery through various routes of administration. Nanoparticles (NP) prepared using chitosan and chitosan derivatives typically possess a positive surface charge and has mucoadhesive properties such that they can adhere to mucus membranes and release the drug in a sustained release manner. They have various applications for the treatment of cancer, gastrointestinal diseases, pulmonary diseases, drug delivery to the brain and ocular infections through non-parenteral route of drug delivery.

Metrics

Metrics Loading ...

References

Panda BP, Patnaik S and Maharana RL. (2017). Current trends in design and development of Nanopharmaceutical dosage forms. Bioequivalence and Bioavailability International Journal, 1(1), 104.

Ali A and Ahmed S. (2018). A review on chitosan and its nanocomposites in drug delivery. International Journal of Biological Macromolecules, 109, 273-286.

Mohammed MA, Syeda JTM, Wasan KM and Wasan EK. (2017). An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery. Pharmaceutics, 9(4), 53.

Cui F, He C, Yin L, Qian F, He M, Tang C and Yin C. (2007). Nanoparticles Incorporated in Bilaminated Films: A Smart Drug Delivery System for Oral Formulations. ACS Publications, 8(9), 2845-2850.

Pedro M.C, Flávia S, Rui M, Victor M, Pizones RH, Ana M.R.P, Ana RM, Bruno S and Manuela E.P. (2018). Incorporation of beads into oral films for buccal and oral delivery of bioactive molecules. Carbohydrate polymers, 194, 411-421.

Morales JO and Brayden DJ. (2017). Buccal delivery of small molecules and biologics: of mucoadhesive polymers, films, and nanoparticles. Current Opinion in Pharmacology, 36, 22-28.

Shen BD, Shen CY, Yuan XD, Bai JX, Lv QY, Xu H, Dai L, Yu C, Han J and Yuan HL. (2013). Development and characterization of an orodispersible film containing drug nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics, 85, 1348-1356.

Jing-jing G, Peng-Fei Y, Jun-lan L, JinHana S, FuaShi-X, JinaShi-Y, Hai-Long Y. (2013). Development and in vivo/in vitro evaluation of novel herpetrione nanosuspension. International Journal of Pharmaceutics, 227-233.

Mazzarino L, Borsali R and Lemos-Senna E. (2014). Mucoadhesive Films Containing Chitosan‐Coated Nanoparticles: A New Strategy for Buccal Curcumin Release. Journal of Pharmaceutical Sciences, 103(11), 3764-3771.

Chonkar AD, Rao JV, Managuli RS, Mutalik S, Dengale S, Jain P and Udupa N. (2016). Development of fast dissolving oral films containing lercanidipine HCl nanoparticles in semicrystalline polymeric matrix for enhanced dissolution and ex vivo permeation. European journal of Pharmaceutics and Biopharmaceutics, 103, 179-191.

Kevadiya BD, Barvaliya M, Zhang L, Anovadiya A, Brahmbhatt H, Paul P and Tripathi C. (2018). Fenofibrate Nanocrystals Embedded in Oral Strip-Films for Bioavailability Enhancement. Bioengineering, 5(1), 1.

Soroushnai A1, Ganji F1, Vasheghani-Farahani E1 and Mobedi H2. (2018). Development and Evaluation of an Anti-Epileptic Oral Fast-Dissolving Film with Enhanced Dissolution and In vivo Permeation. Current Drug Delivery, 1294-1304.

Kilor, V., Sapkal, N., Daud, A., Humne, S. and Gupta, T. (2017). Development of stable nanosuspension loaded oral films of glimepiride with improved bioavailability. International Journal of Applied Pharmaceutics, 9(2), 28-33.

Chen L, Daoxiao C, Xinhui Z, Hong S, Yindi K, Rongyue Z, and Wenping W. (2017). Oral fast-dissolving films containing lutein nanocrystals for improved bioavailability: formulation development, in vitro and in vivo evaluation. AAPS PharmSciTech, 18(8).

Bharti K, Mittal P and Mishra B. (2019). Formulation and characterization of fast dissolving oral ﬁlms containing buspirone hydrochloride nanoparticles using design of experiment. Journal of Drug Delivery Science and Technology, 49, 420-432.

Qing S, Chengying S, Baode S, Wangquan L, Xiao L, Bo Dai and Hailong Y. (2018). Development of a fast dissolving sublingual film containing meloxicam nanocrystals for enhanced dissolution and earlier absorption. Journal of Drug Delivery Science and Technology, 243-252.

Castro PM, Baptista P, Madureira AR, Sarmento B and Pintado ME. (2018). Combination of PLGA nanoparticles with mucoadhesive guar-gum films for buccal delivery of antihypertensive peptide. International Journal of Pharmaceutics, 547(1-2), 593-601.

CL Ventola. (2017). Progress in Nanomedicine: Approved and Investigational Nanodrugs. Pharmacy and Therapeutics, 742-755.